Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.

Matsuno, Hiroaki

Matsuno, Hiroaki.

Affiliation

Matsuno H; Matsuno Clinic for Rheumatic Diseases, 7187-2 Kureha, Toyama, Toyama, 930-0138, Japan. info@toyama-ra.com.

Drugs R D ; 16(4): 347-353, 2016 Dec.

Article in En | MEDLINE | ID: mdl-27766589

Subject(s)

Arthritis, Rheumatoid/drug therapy; Bone Density/drug effects; Denosumab/therapeutic use; Glucocorticoids/therapeutic use; Osteoporosis/drug therapy; Administration, Oral; Aged; Case-Control Studies; Denosumab/administration & dosage; Denosumab/adverse effects; Female; Glucocorticoids/administration & dosage; Humans; Injections, Subcutaneous; Middle Aged

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Arthritis, Rheumatoid / Bone Density / Denosumab / Glucocorticoids Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Drugs R D Journal subject: TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Japan Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google